BioDiscovery: Advanced Open Access Journal in Life Sciences and Medicine
The Marine Biodiscovery Pipeline - University of Aberdeen Timeline 04 The Marin… · The Marine...
Transcript of The Marine Biodiscovery Pipeline - University of Aberdeen Timeline 04 The Marin… · The Marine...
The Marine Biodiscovery Pipeline Marcel Jaspars Marine Biodiscovery Centre University of Aberdeen Scotland, UK [email protected]
2
Professor Marcel Jaspars
• Professor of Organic Chemistry, University of Aberdeen • Director of Marine Biodiscovery Centre, University of
Aberdeen • Project Leader, PharmaSea EU FP7 Consortium • Co-Author of ESF Marine Board Position Paper “Marine
Biotechnology – A New Vision and Strategy for Europe” • Visiting Professor and Scientific advisor at University of
Tromsø • Member of the governing board of the Industrial
Biotechnology Innovation Centre
3
Why Use Marine Bioresources?
Offers advantage over comparable terrestrial resource: Superior performance Better economics Unprecedented activity in particular application:
Enzymes: new reactivity/new biotransformation Small molecules: new mechanism of action Materials: new properties
4
Biodiscovery is the discovery
of compounds and associated ideas from natural sources to develop novel biomedicines. Biodiscovery generates
chemical diversity that is used to find initial biological activity in disease focused screens Biodiscovery also includes
the development of biomedical research tools, antifoulants, catalysts, nutraceuticals and cosmeceuticals.
The Marine Biodiscovery Process
Development
Sampling
Curation
Biomass
Extraction
Assay
Purification
Active NCE
Progress: >1,200 >11,000 starting……
PharmaSea: Increasing Value and Flow in the Marine Biodiscovery Pipeline
7
Extreme Marine Environments
Deep Oceans 95 % > 1000 m deep 50 % > 3000 m deep Average depth = 3790 m 1-3% trench ecosystems
Cold Oceans
Thermal Vents
8
Marine Animal Biodiversity
0
1
2
3
4
5
Porifer
a
Placoz
oa
Cnidari
a
Ctenop
hora
Platyh
elmint
hes
Gnatho
stomuli
da
Nemert
ea
Nemato
da
Rotifer
a
Gastro
tricha
Kinorhy
ncha
Loric
ifera
Tardigr
ada
Priapu
la
Mollus
ca
Kampto
zoa
Pogon
opho
ra
Sipunc
ula
Echiur
a
Anneli
da
Onych
opho
ra
Crustac
ea
Chelice
rata
Uniram
ia
Chaeto
gnath
a
Phoron
ida
Brachio
poda
Bryozo
a
Echino
derm
ata
Hemich
ordata
Urocho
rdata
Cepha
locho
rdata
Verteb
rata
Phylum
Spec
ies
estim
ate
(Log
) MarineTerrestrial
9
Marine Microbial Diversity
Streptoverticilum
Taxonomic ‘space’ Marine and terrestrial species clearly separated.
10
Biological Diversity = Chemical Diversity
H
NNH H
Br N
O
N
OH
BrO
Br
N
N
O
HO
Br
O
OH
OH
COOH
OO
OH
O
O
O
OH
OOH
O
OH
HOOH
OH
OH
O
OH
HOOH
N
HO
H
HH
HO
NN
NOH
N+H
H
H
OH
H3C
O
OH
O
OHO
O
O
HOH
H H
H
OHHO O
HO
O
H
H
OHOH
HHO
O
O
NHN
S
HN
SN
NH
O
O
ON
N
O
O
O
O
HO
H
OHOOH
OH
O
HN
N
N
O
OO
N
HN
O
N
O NH
HN
O
HN
O
HN
N
HN
N
OO
OO
HN
O
HN
NH
NNH
OO
O
OH
ON
OMe
BrBr
HN
OO
Br
Br
HO
R
HN
N
O
OHMeO
Br
Br
O R
Br
Small Molecules Biomolecules
11
Marine and Terrestrial Chemical Diversity are Different
• 71% of scaffolds are exclusively marine
• These cover only 30% of marine natural products
• Many marine natural products scaffolds appear only once
Kong, Drug Discovery Today, 2010, 15, 884
12
Marine Natural Products on the Market
Vent Polymerase Origin: Vent bacterium Production: Recombinant
ω-3 polyunsaturated fatty acids for heart disease Origin: Fish Production: Fish
Prialt for pain Origin: Phillippino cone snail
Production: Recombinant
Halaven for cancer Origin: Japanese deep water sponge Production: Chemical synthesis
13
The Marine Biodiscovery Process
Development
Sampling
Curation
Biomass
Extraction
Assay
Purification
Active NCE
15
Current Cruise Protocols Very Heterogeneous
Application • Cruise path/stations/equipment.
Award
• Clarification for feasibility/equipment availability. • Check MPAs not entered.
After Cruise
• Data is logged with central agency – cruise report • Sample list/locations collected/location stored • Environmental data/images and video
No requirement for post cruise data (eg genetic data) to be deposited Species may not be identified until later, if at all
17
Research Vessels
• High daily rate • Limited number of vessels globally • Access competitive • Long time between bid for time and actual cruise • Many different types of science accommodated may lead to compromises • Shared resources and bartering systems operate to optimise usage
RRS Discovery (UK) Chikyu (Japan)
18
Alternatives for Collection in ABNJ
Charter Vessels Rapid access Lower cost Dedicated to one task No requirement to deposit data Foundation Vessels Different requirements, eg image copyright, open access data etc Survey Vessels Baseline surveys for companies often carried out by ‘neutral’ academic institutions Data can be used for publication with agreement No requirement to deposit data Cruise path may be commercially sensitive
19
Submersibles
ROV Isis (UK) (6500 m)
Shinkai (Japan) (6500 m)
ROV Nereus (US) (11000 m)
Deepsea challenger (US) (11000 m)
22
The Marine Biodiscovery Process
Development
Sampling
Curation
Biomass
Extraction
Assay
Purification
Active NCE
23
Metadata may include Location Depth Temperature Salinity pH Oxygen content Seafloor conditions
Sample Data and Storage
Sample storage Ambient temperature Cooler (4oC) Freezer (-20oC) -80oC Freezer Liquid nitrogen (-196oC) Formaldehyde Ethanol DNA/RNA preservation liquids
24
Are Current Repositories Sufficient?
Further sampling is essential for the following reasons: • Origin may be difficult to ascertain (eg location, depth, collector,
date, ownership etc). A minimal data set is imperative. • IP status not clear • May not have been collected in a way consistent with proposed use • May not have been stored correctly to ensure sufficient quality for
proposed use. • The amount of material may not be sufficient for proposed multiple
uses. • Very few locations have been sampled so repository may not be
representative of ABNJs.
25
If previous points can be addressed then such a repository might be viable • The rules for terrestrial biorepositories may not apply for
their marine equivalent. • Much information on biorepositories is based on situation
with respect to plants where samples can be propagated. • A deepsea core sample or a marine macroorganism
collected on one sampling expedition is finite. • Microbes can be cultured but again culturing a microbe
from a hydrothermal vent is quite different from culturing a microbe from a terrestrial habitat.
An ABNJ Sample Biorepository?
26
The Marine Biodiscovery Process
Development
Sampling
Curation
Biomass
Extraction
Assay
Purification
Active NCE
28
The Marine Biodiscovery Process
Development
Sampling
Curation
Biomass
Extraction
Assay
Purification
Active NCE
29
Extraction and Purification
Solvent-solvent partition
Size-exclusion chromatography High performance
Liquid chromatography
30
The Marine Biodiscovery Process
Development
Sampling
Curation
Biomass
Extraction
Assay
Purification
Active NCE
31
Assay
S1Inactive
S2Inactive
S3Inactive
S4Inactive
S6F1Inactive
S6F2Inactive
S6F3Inactive
S6F4H1Inactive
S6F4H2Inactive
Pure CompoundActive
S6F4Active
S5Active
S6Inactive
Crude extractActive
Cell based Enzyme based
32
The Marine Biodiscovery Process
Development
Sampling
Curation
Biomass
Extraction
Assay
Purification
Active NCE
33
Structure Determination
Spectroscopic data
NH SO
N N
NH
ON
NH
S
NNH
O
O
O
O 2D Structure
3D Structure
34
Metagenomic Approach
Prochloron gDNA
VTACITFC TACITFCV ACITFCVT CITFCVTA ITFCVTAC TFCVTACI FCVTACIT CVTACITF
Genome sequencing
Search for all permutations
50000bp
50000bp
50000bp
Shotgun cloning
E. coli clone library
Identification of biosynthetic
pathway
1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
E
F
G
H
Positive plate1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
E
F
G
H
Positive column
1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
E
F
G
H
Positive well
LC-MS deconvolution of clone library
50000bp
50000bp
50000bp
Cloning and heterologous
expression of pathway
50000bp
Identification of productive clones
Sequencing
gDNA
NH
SO
N N
HN
ON
NH
S
N HN
R1
O
O
O
R4
O
R2
R3
Product
35
Bioinformatic Databases and the Metagenomic Approach
• Who acquired/deposited the data and with what authority?
• Who has access to the data? • Is genome and metagenome information
sufficient? • Many genes found in marine species are
not in the current bioinformatic databases • The function of many of these genes
cannot be determined without laboratory work
• Difficulty in cloning genes of marine origin • Lack of suitable tools (vectors/hosts)
0
200
100 300
400
50
150 250
350
EhV-86 407,339 bp
36
Gene Synthesis
GATTACAGGACGCTT ATTTTTCGACGATGC TTGGGGAAATGCAAA GATTCAGCTAAAGTC
Gene sequence
DNA
Protein Molecule
37
Conclusions
• The marine environment clearly provides an exciting source of new bioactive compounds
• The marine environment and its biodiversity is largely unexplored compared to the terrestrial environment and so cruises and sampling will continue and are necessary for both basic and applied research purposes
• A greater degree of coordination of relevant activities within the scientific community is necessary at a global level
• Capacity building is required to support these efforts